Pediatric Trials Network

  • PTN Research Informs Fluconazole Label Change February 16, 2024

    Data from multiple Pediatric Trials Network (PTN) studies contributed to a recent U.S. Food and Drug Administration (FDA) label change for fluconazole. The data ...

Results At-A-Glance

The Pediatric Trials Network works to make medication safer and more effective for all children. As part of that work, we share what we learn with all stakeholders through result summaries. We appreciate every family who participates in research and makes this work possible.

Evidence Into Practice
The leader in pediatric research of off-patent drugs

The PTN provides pediatricians, researchers, and regulators with new information on how children respond to medications. Studies are conducted primarily with off-patent drugs that are lacking data on safety, efficacy, and dosing in pediatric populations. The primary goal is to generate the data necessary to produce evidence-based clinical practice guidelines.